Klotho Neurosciences Inc. is a pharmaceutical company. It specializes in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system which are seen as key developments in treating neurodegenerative and age-related disorders. Klotho Neurosciences Inc., formerly known as ANEW MEDICAL INC., is based in NEW YORK.
Info & Links
CEO
Jiande Chen
Headquarters
1115 BROADWAY, 12TH FLOOR New York, NY 10010, UNITED STATES
Klotho Neurosciences, Inc. Common Stock Statistics
Valuation Measures
Market Capitalization2
7.76M
Enterprise Value
7.86M
Enterprise Value/EBITDA(ttm)
-1.86
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
--
Price to Book(mrq)
4.41
Price to Cash(ytd)
0.95
Profitability
Gross Margin(ttm)
0.00%
Operating Margin(ttm)
--
Profit Margin(ttm)
0.00%
Return on Equity(ttm)
--
Return on Invested Capital(ttm)
-108.96%
Return on Assets(ttm)
-25.89%
Income Statement
Revenue(ttm)
0.00
Revenue Per Share(ttm)
0.00
Gross Profit(ttm)
0.00
EBITDA(ttm)3
-4.22M
Net Income Available to Common(ttm)
-2.90M
Diluted EPS(ttm)
--
Share Statistics
Beta (5Y Monthly)
--
52-Week Change
--
S&P 500 52-Week Change
18.16%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
21.26M
Dividend Yield
0.00%
Float4
26.54M
% Held by Insiders
2.00%
% Held by Institutions
20.07%
Balance Sheet
Total Cash(mrq)
50.90K
Total Cash Per Share(mrq)
0.00
Total Debt(mrq)
151.00K
Total Debt/Equity(mrq)
10.34%
Current Ratio(mrq)
0.16%
Quick Ratio(mrq)
0.16%
Book Value Per Share(mrq)
0.07
Cash Flow
Operating Cash Flow Per Share(ytd)
-0.12
Free Cash Flow(ytd)
-2.00M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.